| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |